Format

Send to

Choose Destination
See comment in PubMed Commons below
Transpl Int. 2013 Sep;26(9):938-48. doi: 10.1111/tri.12140. Epub 2013 Jul 4.

Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma.

Author information

1
Erasmus MC, Rotterdam, The Netherlands. t.vangelder@erasmusmc.nl

Abstract

Following the first joint meeting organized by the European (ESOT) and American (AST) Societies of Transplantation in 2010, a second joint meeting was held in Nice, France, on October 12-14, 2012 at the Palais de la Mediterannee. Co-chairs of the scientific advisory committee were Dr. Flavio Vincenti (AST) and Dr. Teun Van Gelder (ESOT). The goal was to discuss the key unmet needs in solid organ transplantation with the opportunity to interrelate current basic research efforts with clinical translation. Thus, the topic of this second meeting "Transformational therapies and diagnostics in transplantation" was devised and a summary of this meeting follows.

KEYWORDS:

antibody-mediated rejection; costimulation; delayed graft function; ischemia-reperfusion injury; sensitization; tolerance

PMID:
23822608
DOI:
10.1111/tri.12140
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center